glp 1 agonists thyroid cancer New evidence continues to shape what we know about GLP-1 medications. A June 2026 real-world study followed nearly 400,000 adults starting GLP-1 receptor agonists. Key findings: ⚡️ No increased risk Increased Thyroid Cancer Risk Not
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



























